Table 3.
Parameters/days | Groups/treatment | |||
---|---|---|---|---|
T0 (0.0) | T1 (300 μg/L) | T2 (600 μg/L) | T3 (900 μg/L) | |
ROS (optical density) | ||||
10 | 0.56 ± 0.03 | 0.57 ± 0.01 | 0.63 ± 0.01 | 0.71 ± 0.02∗ |
20 | 0.53 ± 0.01 | 0.59 ± 0.02 | 0.65 ± 0.07∗ | 0.74 ± 0.03∗ |
30 | 0.57 ± 0.01 | 0.62 ± 0.02 | 0.70 ± 0.05∗ | 0.78 ± 0.07∗ |
TBARS (nmol/TBARS formed/mg protein/min) | ||||
10 | 28.51 ± 1.51 | 30.21 ± 1.11 | 35.92 ± 0.5∗ | 39.63 ± 1.39∗ |
20 | 29.08 ± 1.63 | 31.08 ± 1.16 | 37.07 ± 0.6∗ | 41.06 ± 1.83∗ |
30 | 29.72 ± 1.71 | 33.79 ± 1.17 | 37.79 ± 0.7∗ | 41.83 ± 1.77∗ |
Reduced GSH (μmol/g tissue) | ||||
10 | 7.70 ± 0.3 | 6.45 ± 0.3 | 5.21 ± 0.2∗ | 3.95 ± 0.2∗ |
20 | 7.66 ± 0.3 | 6.35 ± 0.2 | 5.18 ± 0.2∗ | 3.82 ± 0.2∗ |
30 | 7.54 ± 0.3 | 6.31 ± 0.2 | 5.10 ± 0.2∗ | 3.79 ± 0.2∗ |
Antioxidant enzymes | ||||
SOD (units/mg protein) | ||||
10 | 15.51 ± 0.36 | 13.53 ± 0.35 | 11.56 ± 0.33∗ | 9.55 ± 0.32∗ |
20 | 15.40 ± 0.36 | 13.14 ± 0.35 | 10.99 ± 0.33∗ | 8.77 ± 0.32∗ |
30 | 15.26 ± 0.36 | 13.10 ± 0.35 | 10.86 ± 0.33∗ | 8.68 ± 0.32∗ |
CAT (units/min) | ||||
10 | 5.12 ± 0.1 | 4.58 ± 0.09 | 3.84 ± 0.09∗ | 3.46 ± 0.07∗ |
20 | 5.08 ± 0.1 | 4.56 ± 0.09 | 3.78 ± 0.08∗ | 3.43 ± 0.07∗ |
30 | 5.04 ± 0.1 | 4.45 ± 0.09 | 3.62 ± 0.08∗ | 3.30 ± 0.06∗ |
POD (units/μg) | ||||
10 | 5.98 ± 0.13 | 5.33 ± 0.13 | 4.17 ± 0.11∗ | 4.04 ± 0.10∗ |
20 | 5.92 ± 0.13 | 5.30 ± 0.12 | 4.13 ± 0.11∗ | 3.95 ± 0.10∗ |
30 | 5.89 ± 0.13 | 5.27 ± 0.12 | 4.03 ± 0.10∗ | 3.89 ± 0.10∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.